Fukushima Translational Research Foundation

Our goal is to facilitate Fukushima’s bright future through contributions to the reconstruction after the Great East Japan Earthquake disaster.

We are working to contribute to the reconstruction by establishing and promoting the pharmaceutical-related industries by working collaboratively with the Translational Research Center at Fukushima Medical University and its associated companies.

Link to Translational Research Center at Fukushima Medical University

Topics

We will provide Japanese Cancer Genome Analysis Data for a fee

-Whole Exome Sequence Analysis of Japanese patients with cancer performed in Fukushima Translational Research Project.

-Tumor-Normal pair analysis providing only Tumor-Specific Variants and no personally genomic information

-Unpublished variant data

-Obtained informed consent (IC) to be able to utilize for both domestic and foreign companies

-No restriction to the purpose to utilize data

-Exclusive contract for all data to use also available

Click here to read more >

A report on antibody profiling in blood of individuals recovering from COVID-19 is now available.

-We will present a report on antibody profiling in blood of COVID-19 recovering patients obtained in the Fukushima project.

-The raw data is also available freely.

Click here to read more >

Vision

Conduct innovative research and engage in challenging development that meet the needs of medical care and patients with substantial expertise and a broad perspective on life sciences, healthcare, and medicine, through collaborations between industry, academia, and government
Based on the “Fukushima Collection®,” achievements created in Fukushima, we continue to contribute to the reconstruction of Fukushima and at the same time, improve human health through the creation of new industries and the vitalization of life science-related industries
Develop excellent human resources using life science-related technologies

Mission

Contribute to the improvement of human health using proprietary life science technologies
Create new industries based on the achievements created in Fukushima
Aim for Fukushima’s bright future through contributions to its reconstruction after the Great East Japan Earthquake disaster

Project

Providing the Databases

F-PDO, F-PDX, and cancer cells

Gene expressions
Genomic analyses
Anticancer drug sensitivity
Clinical information

Conducting contract research using F-PDO, F-PDX, and cancer cell lines

We can also provide F-PDO and F-PDX.

(links to outlines of F-PDO and F-PDX)

Antibody profiling using a protein microarray

Binding to human proteins
Binding and cross-reactivity

Conducting contract testing using a protein microarray

Please contact us if you are interested.

(link to outlines of protein microarray)

Research and development consulting

Consulting for research and development work with databases and deliverables.

Greeting

At the Translational Research Center at Fukushima Medical University (TR center), we have been promoting the Fukushima Translational Research Project (Fukushima Project), launched as a part of the post-Great East Japan Earthquake reconstruction measures. The purpose of the Fukushima Project is to provide development support for pharmaceutical and medical testing/IVD industries and reagent manufacturers, as well as to create new biological industries and provide employment in Fukushima.

To ensure the stability of our project in the future, we established the Fukushima Translational Research Foundation on February 3, 2020. We will play a role in further promoting the transfer of the project’s research and development results (Fukushima Collection®) to industries, in fields where it is difficult for Fukushima Medical University to proactively utilize the results of research and development, by building a close working relationship with the TR center.

Through this project, we aim to support research and development for members and to create and accumulate pharmaceutical-related industries by working collaboratively with the TR center and TR center-initiated venture companies.

We would like to ask for your continual support and encouragement.

Chairman, Shun-ichiro Iemura

Link to Translational Research Center at Fukushima Medical University

Organization